Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.
Bsteh G, Assar H, Gradl C, Heschl B, Hiller MS, Krajnc N, Di Pauli F, Hegen H, Traxler G, Leutmezer F, Wipfler P, Zulehner G, Guger M, Enzinger C, Berger T; AUT-MuSC-19 investigators. Bsteh G, et al. Among authors: leutmezer f. Eur J Neurol. 2022 Jun 25:10.1111/ene.15477. doi: 10.1111/ene.15477. Online ahead of print. Eur J Neurol. 2022. PMID: 35751475 Free PMC article.
Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.
Salhofer-Polanyi S, Windt J, Sumper H, Grill H, Essmeister M, Diermayr G, Zebenholzer K, Leutmezer F, Zulehner G, Vass K, Asenbaum-Nan S. Salhofer-Polanyi S, et al. Among authors: leutmezer f. NeuroRehabilitation. 2013;33(2):285-92. doi: 10.3233/NRE-130956. NeuroRehabilitation. 2013. PMID: 23949063 Clinical Trial.
Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.
Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W. Aboul-Enein F, et al. Among authors: leutmezer f. PLoS One. 2013 Nov 5;8(11):e79649. doi: 10.1371/journal.pone.0079649. eCollection 2013. PLoS One. 2013. PMID: 24223985 Free PMC article.
Epidemiology of Multiple Sclerosis in Austria.
Salhofer-Polanyi S, Cetin H, Leutmezer F, Baumgartner A, Blechinger S, Dal-Bianco A, Altmann P, Bajer-Kornek B, Rommer P, Guger M, Leitner-Bohn D, Reichardt B, Alasti F, Temsch W, Stamm T. Salhofer-Polanyi S, et al. Among authors: leutmezer f. Neuroepidemiology. 2017;49(1-2):40-44. doi: 10.1159/000479696. Epub 2017 Aug 19. Neuroepidemiology. 2017. PMID: 28848208
Real-life clinical use of natalizumab and fingolimod in Austria.
Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T. Guger M, et al. Among authors: leutmezer f. Acta Neurol Scand. 2018 Feb;137(2):181-187. doi: 10.1111/ane.12864. Epub 2017 Nov 20. Acta Neurol Scand. 2018. PMID: 29159801
Month-of-birth-effect in multiple sclerosis in Austria.
Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F. Walleczek NK, et al. Among authors: leutmezer f. Mult Scler. 2019 Dec;25(14):1870-1877. doi: 10.1177/1352458518810924. Epub 2018 Nov 22. Mult Scler. 2019. PMID: 30463473
Real-life use of oral disease-modifying treatments in Austria.
Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR). Guger M, et al. Among authors: leutmezer f. Acta Neurol Scand. 2019 Jul;140(1):32-39. doi: 10.1111/ane.13097. Epub 2019 Apr 22. Acta Neurol Scand. 2019. PMID: 30958901 Free PMC article.
142 results